VeriSIM Life

Drug Discovery · Biotechnology
$1.4Mraised in 3 rounds
3backers · Amplify Partners, OCA Ventures
$1.4Mgrants · 3 grants · CORDIS
10+team · employees, estimated range

Overview

Make confident decisions about drug development, quickly and efficiently, using a decision-engine that takes your toughest translational questions and generate actionable insights to guide your next steps.

Funding and backers

Team
11-50
employees, estimated range
Grants
$1.4M
3 grants · CORDIS
Backers
3
Amplify Partners, OCA Ventures
Momentum
15/100
in the news
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 1, 2025 Won a grant $812k · CORDIS May 26, 2022 Partnership VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to Develop New Drugs for Neurological Disorders · businesswire.com Apr 1, 2022 Won a grant $312k · CORDIS Jan 15, 2021 Won a grant $256k · CORDIS 2017 Founded
Funding rounds
RoundDateAmountInvestorsSource
Grant Aug 2025 $812k — CORDIS
Grant Apr 2022 $312k — CORDIS
Grant Jan 2021 $256k — CORDIS
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Abinitio bio is the AI-native operating platform for drug development and manufacturing.
Psylink is a biotechnology company offering a novel solution to psychedelic drug development.
Discover KolateAI's innovative platform that leverages AI and real-world data to optimize clinical trials and drug development. Empowering…
Analyst-grade AI system that answers complex questions across millions of references to optimize drug development and clinical trials.
Babylon is a drug development company pursuing a transformational treatment for Alzheimer’s. Meet our team and explore how we discover…
WeatherdenVenture round · 2 mo ago · Founded 2014
Weatherden is a global drug development consultancy helping biotech and pharma realize the full potential of their science and investment.

Financials

Total raised
$1.4M
Latest round
Grant
Funding rounds
3
Funding rounds
Round Announced Amount
Grant 2025 $812k Details
Grant 2022 $312k Details
Grant 2021 $256k Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors3
26 portfolio companies: Wegive, SysGit, Inhouse and 23 more
OCA VenturesVia a fund
75 portfolio companies: Morphic, WhiteFox Defense, Zammo and 72 more
118 portfolio companies: Engram, Warpstream, YeshID and 115 more

News

News pharmexec.com 2 months ago
How Technology is Moving the Industry Away from Animal Testing: Q&A with Dr. Jo Varshney PharmExec
New technologies are helping the industry move toward more predictive and humane approaches.
Read more
Report
News LAist 1 year ago
Election day check in: redistricting and Prop 50
Today on AirTalk, Election day: Prop 50; Gen Z nostalgia; Rose Bowl/UCLA lawsuit; AI drug development, and What to do when your friend cheats.
Read more
Report
Hybrid AI Is Reshaping Drug Development-But Will Transparency Be the Ultimate Proof of Safety?
The United States is facing the worst drug shortage crisis in decades. Essential medicines, from antibiotics to pediatric cancer therapies, are running short. At the same time, the FDA is moving away from mandatory animal testing, creating both urgency an
Read more
Report
News BioTuesdays 1 year ago
VeriSIM delivering predictive insights to advance and de-risk drug development
Closely held VeriSIM Life is leveraging multi-disciplinary quantitative methods to predict patient outcomes and accelerate the discovery, development, and commercialization of transformative therapies. The company aims to eliminate inefficiencies and inac
Read more
Report
News Investment Bank 1 year ago
The Move to the Edge - what drives this next leg of GenAI growth?
Highlights from the UBS Global Technology and AI Conference 2024
Read more
Report
Award Great Companies 2 years ago
Dr. Jo Varshney: Winner of the 2024 Great Companies International Women Entrepreneur Award
With an average timeline of 13 years for drug discovery and development, millions of dollars and lives are lost due to failed drug candidate
Read more
Report
How Do We Build Trust and Transparency in AI?
AI is fast tracking new therapies, but speed means nothing if we can't trust the systems.
Read more
Report
Show more news

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco United States
HQ
10-50 est. staff